Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Johnsonii N6.2 in Children and Adolescents With T1D
NCT03961854Phase 2Completed
- Sponsor
- University of Florida
- Start
- Oct 2019
- Primary completion
- Jan 2026
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus johnsonii n6.2 in type 1 diabetes mellitus (T1D), sponsored by University of Florida. Started Oct 2019; status: completed.
02
Drugs
lactobacillus johnsonii n6.2
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03961854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961854.